Honest

HNST · NASDAQ

$5.07+$0.095 (+1.91%)TodayMarket closed · Oct 20, 7:35 PM ET

Prev close $4.97

HNST analyst rating

HoldConsensus of 6 analysts over the last 12 months. 50% rate it a buy.

Strong buy0
Buy3
Hold2
Underperform1
Sell0

12-month price target · 8 analysts

Average $5.30 (+4.7% upside)

Low: $5.05
Now: $5.07
High: $5.99

Upgrades and downgrades

The latest rating actions, newest first

HNST analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Morgan Stanley	Aug 13, 2026	Maintains	Equal-Weight	$3.40 → $5.70	67%
Telsey Advisory Group	Aug 6, 2026	Maintains	Market Perform	$4.00 → $5.00	47%
B. Riley Securities	Aug 6, 2026	Maintains	Buy	$4.00 → $5.00	34%
Telsey Advisory Group	Feb 26, 2026	Maintains	Market Perform	$3.00	47%
Freedom Broker	Feb 26, 2026	Maintains	Buy	$3.20 → $3.00	50%
Telsey Advisory Group	Feb 19, 2026	Maintains	Market Perform	$3.00	47%
JP Morgan	Jan 16, 2026	Downgrade	Overweight → Underweight	—	58%
Freedom Broker	Dec 8, 2025	Initiates	Buy	$3.20	44%
Morgan Stanley	Nov 19, 2025	Maintains	Equal-Weight	$4.25 → $3.00	67%
Telsey Advisory Group	Nov 6, 2025	Maintains	Market Perform	$6.00 → $3.00	47%

The case for and against

Updated Aug 11, 2026

Bull case

Honest Co is taking aggressive steps towards operational excellence and an improved financial profile, including cost-saving measures expected to generate $10-$15 million in annual savings and an improvement in margins. The company has a strong digital presence and is well-positioned in an attractive category appealing to conscious consumers. However, it faces risks related to consumer demand trends, macroeconomic factors, and the exiting of lower-margin categories, leading to limited visibility in near-term profitability.

Bear case

Honest Co is expected to experience challenges in the diaper category due to shifting retail partners and increasing competition. Their focus on high-margin categories may not be enough to offset declining sales in diapers and apparel. While the company's growth and innovation in other categories is commendable, the negative trends in their largest revenue-generating category raise concerns about their overall performance and profitability in the future.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.